Related Experiment Video
Updated: Aug 14, 2025

Monitoring Neutrophil Elastase and Cathepsin G Activity in Human Sputum Samples
Published on: May 21, 2021
Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 Cleavage
Helen J von Richthofen1,2, Geertje H A Westerlaken1,2, Doron Gollnast1,2
1Center of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Signal inhibitory receptor on leukocytes-1 (SIRL-1) is shed from activated neutrophils, releasing soluble SIRL-1 (sSIRL-1) and diminishing immune function. This shedding is mediated by proteinase 3 and occurs in patients with RSV bronchiolitis and COVID-19.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor on granulocytes and monocytes that reduces antimicrobial functions.
- Previous studies showed decreased SIRL-1 on neutrophils in infants with RSV bronchiolitis and rapid loss upon in vitro activation.
Purpose of the Study:
- To investigate if activated neutrophils lose SIRL-1 via ectodomain shedding.
- To measure soluble SIRL-1 (sSIRL-1) levels in patients with RSV bronchiolitis and COVID-19.
- To elucidate the mechanism and regulation of SIRL-1 shedding.
Main Methods:
- Developed an ELISA to quantify sSIRL-1.
- Measured sSIRL-1 in sputum/plasma of RSV patients and serum of COVID-19 patients.
- Investigated sSIRL-1 release from in vitro activated neutrophils.
- Assessed the effect of proteinase 3 inhibition and Staphylococcus aureus extracellular adherence protein on shedding.
Main Results:
- sSIRL-1 concentrations were elevated in sputum from RSV patients and serum from COVID-19 patients compared to controls.
- In vitro activated neutrophils released sSIRL-1 through proteolytic cleavage, impairing SIRL-1's ability to inhibit reactive oxygen species production.
- SIRL-1 shedding was inhibited by proteinase 3 inhibitors and Staphylococcus aureus extracellular adherence protein.
Conclusions:
- SIRL-1 is released from activated neutrophils via proteinase 3 cleavage, resulting in detectable endogenous sSIRL-1 in vivo.
- SIRL-1 shedding diminishes neutrophil antimicrobial function.
- Staphylococcus aureus may counteract SIRL-1 shedding to maintain its inhibitory function.
More Related Videos
Related Concept Videos
Selectins
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Nitric Oxide Signaling Pathway

